These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 28903988)
1. Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei. Muruato LA; Tapia D; Hatcher CL; Kalita M; Brett PJ; Gregory AE; Samuel JE; Titball RW; Torres AG Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28903988 [No Abstract] [Full Text] [Related]
2. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777 [TBL] [Abstract][Full Text] [Related]
3. Reverse vaccinology and subtractive genomics-based putative vaccine targets identification for Burkholderia pseudomallei Bp1651. Hizbullah ; Nazir Z; Afridi SG; Shah M; Shams S; Khan A Microb Pathog; 2018 Dec; 125():219-229. PubMed ID: 30243554 [TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis. Ngugi SA; Ventura VV; Qazi O; Harding SV; Kitto GB; Estes DM; Dell A; Titball RW; Atkins TP; Brown KA; Hitchen PG; Prior JL Vaccine; 2010 Nov; 28(47):7551-5. PubMed ID: 20837078 [TBL] [Abstract][Full Text] [Related]
6. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders. Burtnick MN; Heiss C; Roberts RA; Schweizer HP; Azadi P; Brett PJ Front Cell Infect Microbiol; 2012; 2():108. PubMed ID: 22912938 [TBL] [Abstract][Full Text] [Related]
7. LVS Δ Tullius MV; Bowen RA; Back PS; Masleša-Galić S; Nava S; Horwitz MA mBio; 2024 Apr; 15(4):e0018624. PubMed ID: 38511933 [TBL] [Abstract][Full Text] [Related]
13. Combating the great mimicker: latest progress in the development of Khakhum N; Chapartegui-González I; Torres AG Expert Rev Vaccines; 2020 Jul; 19(7):653-660. PubMed ID: 32669008 [TBL] [Abstract][Full Text] [Related]
14. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Nieves W; Asakrah S; Qazi O; Brown KA; Kurtz J; Aucoin DP; McLachlan JB; Roy CJ; Morici LA Vaccine; 2011 Oct; 29(46):8381-9. PubMed ID: 21871517 [TBL] [Abstract][Full Text] [Related]
15. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine. Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688 [TBL] [Abstract][Full Text] [Related]
16. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis. Harland DN; Chu K; Haque A; Nelson M; Walker NJ; Sarkar-Tyson M; Atkins TP; Moore B; Brown KA; Bancroft G; Titball RW; Atkins HS Infect Immun; 2007 Aug; 75(8):4173-80. PubMed ID: 17517877 [TBL] [Abstract][Full Text] [Related]
17. Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis. Casey WT; Spink N; Cia F; Collins C; Romano M; Berisio R; Bancroft GJ; McClean S Vaccine; 2016 May; 34(23):2616-21. PubMed ID: 27091689 [TBL] [Abstract][Full Text] [Related]
18. Identification of CD4+ T-cell epitope and investigation of HLA distribution for the immunogenic proteins of Burkholderia pseudomallei using in silico approaches - A key vaccine development strategy for melioidosis. Swetha RG; Sandhya M; Ramaiah S; Anbarasu A J Theor Biol; 2016 Jul; 400():11-8. PubMed ID: 27086038 [TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders. Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962 [TBL] [Abstract][Full Text] [Related]